Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).
Bottom Line: Efficacy and safety data are collected every 6 months for 8 years, and data are extracted annually.Diabetes mellitus type II was reported in 11·4% of patients.The occurrence of most comorbidities, including cardiovascular disease and risk factors, increased with age.
Affiliation: Harvard Medical School and Massachusetts General Hospital, Boston, MA, U.S.A.Show MeSH
Related in: MedlinePlus
Mentions: As of the 23 August 2012 PSOLAR data extract, 11 900 of the 12 000 targeted patients were enrolled at 301 global sites in North America, Europe and Latin America. The first patient was enrolled on 20 June 2007. More than 90% of sites are located in North America (i.e. approximately 75·0% in the U.S.A. and approximately 16·0% in Canada) (Fig.1).
Affiliation: Harvard Medical School and Massachusetts General Hospital, Boston, MA, U.S.A.